Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Valeo Pharma Inc VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

GREY:VPHIF - Post Discussion

Valeo Pharma Inc > Rock and Roll
View:
Post by NAGGY23 on Dec 09, 2020 10:53pm

Rock and Roll

VPH will be 1.50 to $1.75 by end of month ..
Comment by kooter33 on Dec 10, 2020 12:22pm
A lot depends on the Xmas selling.  People may take profits to fund their Xmas. Also depends on VPH management releasing any additional NRs before Xmas.  If they decide to wait until the New Year we will inevitably see the SP range bound between $ 1.15 to $ 1.30 IMO.  The SP is news driven as you saw with the NR about Redesca. JMHO.
Comment by eric40 on Dec 10, 2020 8:01pm
Redeska approval is big awaited news that will a a dramatic impact on 2021 and future revenu. As a generic heparin, the only one available, provinces where it is mandatory to buy generic first if available will have to bur Valeo's generic heparine (Redeska). And I bet that with covid impact on province's deficit,  the rest of the provinces where it is not madatory yet will make it ...more  
Valeo Pharma Inc